129 related articles for article (PubMed ID: 34390292)
41. Fascin 1 promoted the growth and migration of non-small cell lung cancer cells by activating YAP/TEAD signaling.
Liang Z; Wang Y; Shen Z; Teng X; Li X; Li C; Wu W; Zhou Z; Wang Z
Tumour Biol; 2016 Aug; 37(8):10909-15. PubMed ID: 26886283
[TBL] [Abstract][Full Text] [Related]
42. Targeted silencing of TEM8 suppresses non‑small cell lung cancer tumor growth via the ERK/Bcl‑2 signaling pathway.
Gong Q; Deng J; Zhang L; Zhou C; Fu C; Wang X; Zhuang L
Mol Med Rep; 2021 Aug; 24(2):. PubMed ID: 34165155
[TBL] [Abstract][Full Text] [Related]
43. Furry protein suppresses nuclear localization of yes-associated protein (YAP) by activating NDR kinase and binding to YAP.
Irie K; Nagai T; Mizuno K
J Biol Chem; 2020 Mar; 295(10):3017-3028. PubMed ID: 31996378
[TBL] [Abstract][Full Text] [Related]
44. Heterogeneous nuclear ribonucleoprotein A2/B1 regulates the ERK and p53/HDM2 signaling pathways to promote the survival, proliferation and migration of non‑small cell lung cancer cells.
Kim MK; Choi MJ; Lee HM; Choi HS; Park YK; Ryu CJ
Oncol Rep; 2021 Aug; 46(2):. PubMed ID: 34109989
[TBL] [Abstract][Full Text] [Related]
45. Cucurbitacin E inhibits the Yes‑associated protein signaling pathway and suppresses brain metastasis of human non‑small cell lung cancer in a murine model.
Hsu PC; Tian B; Yang YL; Wang YC; Liu S; Urisman A; Yang CT; Xu Z; Jablons DM; You L
Oncol Rep; 2019 Aug; 42(2):697-707. PubMed ID: 31233205
[TBL] [Abstract][Full Text] [Related]
46. Altered expression of 17‑β‑hydroxysteroid dehydrogenase type 2 and its prognostic significance in non‑small cell lung cancer.
Drzewiecka H; Jarmołowska-Jurczyszyn D; Kluk A; Gałęcki B; Dyszkiewicz W; Jagodziński PP
Int J Oncol; 2020 Jun; 56(6):1352-1372. PubMed ID: 32236582
[TBL] [Abstract][Full Text] [Related]
47. Enhanced nuclear localization of YAP1-2 contributes to EGF-induced EMT in NSCLC.
Guo Q; Quan MY; Xu L; Cai Y; Cai JT; Li X; Feng G; Chen A; Yang W; Dhlamini Q; Jiang TF; Shen C; Chen C; Zhang JS
J Cell Mol Med; 2022 Feb; 26(4):1013-1023. PubMed ID: 35014181
[TBL] [Abstract][Full Text] [Related]
48. SIRT6 through PI3K/Akt/mTOR signaling pathway to enhance radiosensitivity of non-Small cell lung cancer and inhibit tumor progression.
Xiong L; Tan B; Lei X; Zhang B; Li W; Liu D; Xia T
IUBMB Life; 2021 Sep; 73(9):1092-1102. PubMed ID: 34033225
[TBL] [Abstract][Full Text] [Related]
49. KDM6B Elicits Cell Apoptosis by Promoting Nuclear Translocation of FOXO1 in Non-Small Cell Lung Cancer.
Ma J; Wang N; Zhang Y; Wang C; Ge T; Jin H; Deng X; Huo X; Gu D; Ge Z; Chu W; Jiang L; Qin W
Cell Physiol Biochem; 2015; 37(1):201-13. PubMed ID: 26303949
[TBL] [Abstract][Full Text] [Related]
50. MEOX1 suppresses the progression of lung cancer cells by inhibiting the cell-cycle checkpoint gene CCNB1.
Xiao X; Rui B; Rui H; Ju M; Hongtao L
Environ Toxicol; 2022 Mar; 37(3):504-513. PubMed ID: 34837450
[TBL] [Abstract][Full Text] [Related]
51. ITGB1 enhances the Radioresistance of human Non-small Cell Lung Cancer Cells by modulating the DNA damage response and YAP1-induced Epithelial-mesenchymal Transition.
Li Y; Sun C; Tan Y; Zhang H; Li Y; Zou H
Int J Biol Sci; 2021; 17(2):635-650. PubMed ID: 33613118
[No Abstract] [Full Text] [Related]
52. Sulforaphane suppresses the viability and metastasis, and promotes the apoptosis of bladder cancer cells by inhibiting the expression of FAT‑1.
Wang F; Liu P; An H; Zhang Y
Int J Mol Med; 2020 Sep; 46(3):1085-1095. PubMed ID: 32705150
[TBL] [Abstract][Full Text] [Related]
53. Assembly and activation of the Hippo signalome by FAT1 tumor suppressor.
Martin D; Degese MS; Vitale-Cross L; Iglesias-Bartolome R; Valera JLC; Wang Z; Feng X; Yeerna H; Vadmal V; Moroishi T; Thorne RF; Zaida M; Siegele B; Cheong SC; Molinolo AA; Samuels Y; Tamayo P; Guan KL; Lippman SM; Lyons JG; Gutkind JS
Nat Commun; 2018 Jul; 9(1):2372. PubMed ID: 29985391
[TBL] [Abstract][Full Text] [Related]
54. DLC-1 tumor suppressor regulates CD105 expression on human non-small cell lung carcinoma cells through inhibiting TGF-β1 signaling.
Zhang K; Na T; Ge F; Yuan BZ
Exp Cell Res; 2020 Jan; 386(2):111732. PubMed ID: 31770531
[TBL] [Abstract][Full Text] [Related]
55. ORP8 induces apoptosis by releasing cytochrome c from mitochondria in non‑small cell lung cancer.
Li J; Cui J; Li Z; Fu X; Li J; Li H; Wang S; Zhang M
Oncol Rep; 2020 May; 43(5):1516-1524. PubMed ID: 32323800
[TBL] [Abstract][Full Text] [Related]
56. COPB2 promotes cell proliferation and tumorigenesis through up-regulating YAP1 expression in lung adenocarcinoma cells.
Pu X; Wang J; Li W; Fan W; Wang L; Mao Y; Yang S; Liu S; Xu J; Lv Z; Xu L; Shu Y
Biomed Pharmacother; 2018 Jul; 103():373-380. PubMed ID: 29674272
[TBL] [Abstract][Full Text] [Related]
57. miR‑593 inhibits proliferation and invasion and promotes apoptosis in non‑small cell lung cancer cells by targeting SLUG‑associated signaling pathways.
Wei F; Wang M; Li Z; Wang Y; Zhou Y
Mol Med Rep; 2019 Dec; 20(6):5172-5182. PubMed ID: 31661137
[TBL] [Abstract][Full Text] [Related]
58. YAP promotes erlotinib resistance in human non-small cell lung cancer cells.
Hsu PC; You B; Yang YL; Zhang WQ; Wang YC; Xu Z; Dai Y; Liu S; Yang CT; Li H; Hu B; Jablons DM; You L
Oncotarget; 2016 Aug; 7(32):51922-51933. PubMed ID: 27409162
[TBL] [Abstract][Full Text] [Related]
59. Melatonin Downregulates PD-L1 Expression and Modulates Tumor Immunity in KRAS-Mutant Non-Small Cell Lung Cancer.
Chao YC; Lee KY; Wu SM; Kuo DY; Shueng PW; Lin CW
Int J Mol Sci; 2021 May; 22(11):. PubMed ID: 34073318
[TBL] [Abstract][Full Text] [Related]
60.
Chen C; Li Y; Liu H; Liao M; Yang J; Liu J
Heliyon; 2024 Apr; 10(7):e28356. PubMed ID: 38560204
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
